A detailed history of Beese Fulmer Investment Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Beese Fulmer Investment Management, Inc. holds 163,608 shares of NVO stock, worth $17.2 Million. This represents 1.71% of its overall portfolio holdings.

Number of Shares
163,608
Previous 163,818 0.13%
Holding current value
$17.2 Million
Previous $23.4 Million 16.69%
% of portfolio
1.71%
Previous 2.17%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$119.07 - $145.42 $25,004 - $30,538
-210 Reduced 0.13%
163,608 $19.5 Million
Q2 2024

Jul 03, 2024

BUY
$122.71 - $146.91 $134,981 - $161,601
1,100 Added 0.68%
163,818 $23.4 Million
Q1 2024

Apr 08, 2024

SELL
$102.11 - $135.92 $107,521 - $143,123
-1,053 Reduced 0.64%
162,718 $20.9 Million
Q4 2023

Jan 09, 2024

BUY
$87.78 - $105.45 $42,485 - $51,037
484 Added 0.3%
163,771 $16.9 Million
Q3 2023

Oct 10, 2023

BUY
$90.94 - $199.54 $7.44 Million - $16.3 Million
81,830 Added 100.46%
163,287 $14.8 Million
Q2 2023

Jul 11, 2023

BUY
$155.98 - $172.65 $181,092 - $200,446
1,161 Added 1.45%
81,457 $13.2 Million
Q1 2023

Apr 11, 2023

BUY
$132.34 - $159.14 $9.02 Million - $10.8 Million
68,138 Added 560.44%
80,296 $12.8 Million
Q4 2022

Jan 17, 2023

BUY
$102.55 - $135.33 $1.25 Million - $1.65 Million
12,158 New
12,158 $0
Q3 2020

Oct 08, 2020

SELL
$63.69 - $70.22 $57,321 - $63,198
-900 Closed
0 $0
Q2 2020

Jul 17, 2020

BUY
$58.54 - $67.94 $52,686 - $61,146
900 New
900 $59,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Beese Fulmer Investment Management, Inc. Portfolio

Follow Beese Fulmer Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beese Fulmer Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beese Fulmer Investment Management, Inc. with notifications on news.